Bristol-Myers Squibb
BMY
#190
Rank
$105.75 B
Marketcap
$51.95
Share price
1.94%
Change (1 day)
-7.84%
Change (1 year)

Operating Margin for Bristol-Myers Squibb (BMY)

Operating Margin as of December 2025 (TTM): 16.72%

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is 16.72%. At the end of 2024 the company had an Operating Margin of -17.35%.

Operating Margin history for Bristol-Myers Squibb from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-17.35%-192.51%
202318.75%12.23%
202216.71%-4.29%
202117.46%-208.03%
2020-16.16%-184.93%
201919.03%-28.07%
201826.45%7.11%
201724.70%-18.89%
201630.45%142.76%
201512.54%-16.36%
201414.99%-15.02%
201317.64%32.87%
201213.28%-59.59%
201132.86%5.46%
201031.16%4.61%
200929.79%10.48%
200826.96%47.6%
200718.27%31.33%
200613.91%-39.88%
200523.13%1.48%
200422.80%-9.14%
200325.09%64.53%
200215.25%23.66%
200112.33%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.60%-24.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06% 85.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
37.87% 126.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12% 74.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
15.12%-9.57%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
16.07%-3.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
18.78% 12.32%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
2.78%-83.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
22.91% 37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
18.91% 13.10%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.